Skip to main content

Table 2 Baseline score and group change in behavior after treatment with TJ-54 for 12 weeks

From: Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study

  

Baseline Group

12-week Group

Group Mean

p1

  

Baseline Group

12-week Group

Group Mean

p1

Measure

 

Mean

SD

Mean

SD

Mean

SD

 

CGI-S

 

6.78

0.83

1.95

0.11

-4.825

0.46

<.0001

ABC-I

(Irritability)

17.4

3.66

0.925

0.971

-16.5

1.46

<.0001

ABC-Total

 

77.8

11.4

6.90

4.84

-70.9

5.21

<.0001

 

Lethargy

23.7

3.68

2.10

1.87

-21.6

1.78

<.0001

 

Stereotypy

9.23

3.78

1.33

1.37

-7.90

1.55

<.0001

 

Hyperactivity

21,7

3.90

1.83

1.89

-19.9

1.67

<.0001

 

Inappropriate speech

5.78

1.25

0.73

0.75

-5.05

0.631

<.0001

  1. 1 Significance by t test.
  2. 2 Negative values indicate a positive change.